Recent Advances of Individual BODIPY and BODIPY-Based Functional Materials in Medical Diagnostics and Treatment

Yuriy S. Marfin, Alexey V. Solomonov, Alexander S. Timin, Evgeniy V. Rumyantsev

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

BACKGROUND: The group of fluorophores on boron dipyrrin platform (4,4- difluoro-4-bora3a,4a-diaza-s-indacene, also known as BODIPY) has attracted much attention in the field of molecular sensorics, including sensing of biomolecules and bioprocesses. Structural diversity of existing BODIPY with ample opportunities of directed modification of compounds makes this class of fluorophores attractive for medical and biological purposes. The recent progress in the design and functionalization of BODIPY allows using them for modification of drug micro- and nanocarriers in order to improve their therapeutic effect in cancer treatment. At the same time, integration of BODIPY into drug carriers provides the possibility of in vitro and in vivo real time imaging of used drug carriers. The high fluorescent intensity and low toxicity of BODIPY granted for conjugation with different biomolecules.

RESULTS: The present review focuses on the recent advances for application of individual BODIPY in medical diagnostics, antimicrobial activity, as well as establishing the role of BODIPY in labeling of biomolecules (e.g. proteins, hormones and DNA). Also the review highlights the potential of BODIPY in functionalization of drug micro- and nanocarriers in order to achieve better therapeutic efficiency compared with non-modified materials. The advantages derived from the use of BODIPY for preparation and modification of drug carriers are critically evaluated and potential for future challenges, especially concerning the design of innovative multi-functional BODIPY-based nanocarriers, is discussed in detail using representative examples from literature.

CONCLUSION: Our objective was to show that BODIPY are powerful tools for bioimaging, labeling of biomolecules and construction of new multifunctional drug carriers.

Original languageEnglish
Pages (from-to)2745-2772
Number of pages28
JournalCurrent Medicinal Chemistry
Volume24
Issue number25
DOIs
Publication statusPublished - 2017
Externally publishedYes

Fingerprint

Functional materials
Drug Carriers
Biomolecules
Therapeutics
Fluorophores
Labeling
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
Boron
Oncology
Therapeutic Uses
Pharmaceutical Preparations
Toxicity
Hormones
Imaging techniques

Keywords

  • Advanced functional and healthcare materials
  • antimicrobial activity
  • boron dipirryns (BODIPY)
  • DNA and RNA
  • in vivo and in vitro cell imaging
  • medical diagnostics
  • molecular sensorics
  • multifunctional drug carriers
  • proteins

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Recent Advances of Individual BODIPY and BODIPY-Based Functional Materials in Medical Diagnostics and Treatment. / Marfin, Yuriy S.; Solomonov, Alexey V.; Timin, Alexander S.; Rumyantsev, Evgeniy V.

In: Current Medicinal Chemistry, Vol. 24, No. 25, 2017, p. 2745-2772.

Research output: Contribution to journalReview article

Marfin, Yuriy S. ; Solomonov, Alexey V. ; Timin, Alexander S. ; Rumyantsev, Evgeniy V. / Recent Advances of Individual BODIPY and BODIPY-Based Functional Materials in Medical Diagnostics and Treatment. In: Current Medicinal Chemistry. 2017 ; Vol. 24, No. 25. pp. 2745-2772.
@article{1e15b8167a17452b9cdf8e0bd8d1882e,
title = "Recent Advances of Individual BODIPY and BODIPY-Based Functional Materials in Medical Diagnostics and Treatment",
abstract = "BACKGROUND: The group of fluorophores on boron dipyrrin platform (4,4- difluoro-4-bora3a,4a-diaza-s-indacene, also known as BODIPY) has attracted much attention in the field of molecular sensorics, including sensing of biomolecules and bioprocesses. Structural diversity of existing BODIPY with ample opportunities of directed modification of compounds makes this class of fluorophores attractive for medical and biological purposes. The recent progress in the design and functionalization of BODIPY allows using them for modification of drug micro- and nanocarriers in order to improve their therapeutic effect in cancer treatment. At the same time, integration of BODIPY into drug carriers provides the possibility of in vitro and in vivo real time imaging of used drug carriers. The high fluorescent intensity and low toxicity of BODIPY granted for conjugation with different biomolecules.RESULTS: The present review focuses on the recent advances for application of individual BODIPY in medical diagnostics, antimicrobial activity, as well as establishing the role of BODIPY in labeling of biomolecules (e.g. proteins, hormones and DNA). Also the review highlights the potential of BODIPY in functionalization of drug micro- and nanocarriers in order to achieve better therapeutic efficiency compared with non-modified materials. The advantages derived from the use of BODIPY for preparation and modification of drug carriers are critically evaluated and potential for future challenges, especially concerning the design of innovative multi-functional BODIPY-based nanocarriers, is discussed in detail using representative examples from literature.CONCLUSION: Our objective was to show that BODIPY are powerful tools for bioimaging, labeling of biomolecules and construction of new multifunctional drug carriers.",
keywords = "Advanced functional and healthcare materials, antimicrobial activity, boron dipirryns (BODIPY), DNA and RNA, in vivo and in vitro cell imaging, medical diagnostics, molecular sensorics, multifunctional drug carriers, proteins",
author = "Marfin, {Yuriy S.} and Solomonov, {Alexey V.} and Timin, {Alexander S.} and Rumyantsev, {Evgeniy V.}",
year = "2017",
doi = "10.2174/0929867324666170601092327",
language = "English",
volume = "24",
pages = "2745--2772",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "25",

}

TY - JOUR

T1 - Recent Advances of Individual BODIPY and BODIPY-Based Functional Materials in Medical Diagnostics and Treatment

AU - Marfin, Yuriy S.

AU - Solomonov, Alexey V.

AU - Timin, Alexander S.

AU - Rumyantsev, Evgeniy V.

PY - 2017

Y1 - 2017

N2 - BACKGROUND: The group of fluorophores on boron dipyrrin platform (4,4- difluoro-4-bora3a,4a-diaza-s-indacene, also known as BODIPY) has attracted much attention in the field of molecular sensorics, including sensing of biomolecules and bioprocesses. Structural diversity of existing BODIPY with ample opportunities of directed modification of compounds makes this class of fluorophores attractive for medical and biological purposes. The recent progress in the design and functionalization of BODIPY allows using them for modification of drug micro- and nanocarriers in order to improve their therapeutic effect in cancer treatment. At the same time, integration of BODIPY into drug carriers provides the possibility of in vitro and in vivo real time imaging of used drug carriers. The high fluorescent intensity and low toxicity of BODIPY granted for conjugation with different biomolecules.RESULTS: The present review focuses on the recent advances for application of individual BODIPY in medical diagnostics, antimicrobial activity, as well as establishing the role of BODIPY in labeling of biomolecules (e.g. proteins, hormones and DNA). Also the review highlights the potential of BODIPY in functionalization of drug micro- and nanocarriers in order to achieve better therapeutic efficiency compared with non-modified materials. The advantages derived from the use of BODIPY for preparation and modification of drug carriers are critically evaluated and potential for future challenges, especially concerning the design of innovative multi-functional BODIPY-based nanocarriers, is discussed in detail using representative examples from literature.CONCLUSION: Our objective was to show that BODIPY are powerful tools for bioimaging, labeling of biomolecules and construction of new multifunctional drug carriers.

AB - BACKGROUND: The group of fluorophores on boron dipyrrin platform (4,4- difluoro-4-bora3a,4a-diaza-s-indacene, also known as BODIPY) has attracted much attention in the field of molecular sensorics, including sensing of biomolecules and bioprocesses. Structural diversity of existing BODIPY with ample opportunities of directed modification of compounds makes this class of fluorophores attractive for medical and biological purposes. The recent progress in the design and functionalization of BODIPY allows using them for modification of drug micro- and nanocarriers in order to improve their therapeutic effect in cancer treatment. At the same time, integration of BODIPY into drug carriers provides the possibility of in vitro and in vivo real time imaging of used drug carriers. The high fluorescent intensity and low toxicity of BODIPY granted for conjugation with different biomolecules.RESULTS: The present review focuses on the recent advances for application of individual BODIPY in medical diagnostics, antimicrobial activity, as well as establishing the role of BODIPY in labeling of biomolecules (e.g. proteins, hormones and DNA). Also the review highlights the potential of BODIPY in functionalization of drug micro- and nanocarriers in order to achieve better therapeutic efficiency compared with non-modified materials. The advantages derived from the use of BODIPY for preparation and modification of drug carriers are critically evaluated and potential for future challenges, especially concerning the design of innovative multi-functional BODIPY-based nanocarriers, is discussed in detail using representative examples from literature.CONCLUSION: Our objective was to show that BODIPY are powerful tools for bioimaging, labeling of biomolecules and construction of new multifunctional drug carriers.

KW - Advanced functional and healthcare materials

KW - antimicrobial activity

KW - boron dipirryns (BODIPY)

KW - DNA and RNA

KW - in vivo and in vitro cell imaging

KW - medical diagnostics

KW - molecular sensorics

KW - multifunctional drug carriers

KW - proteins

UR - http://www.scopus.com/inward/record.url?scp=85030619320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030619320&partnerID=8YFLogxK

U2 - 10.2174/0929867324666170601092327

DO - 10.2174/0929867324666170601092327

M3 - Review article

VL - 24

SP - 2745

EP - 2772

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 25

ER -